Listed

Pediatrix Medical Group, Inc.

MDNYSECIK 893949HealthcareFiscal year ends Dec 31

Reports and events: 259 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Pediatrix Medical Group, Inc., Reports and events
FiledFormWhat it isAccession number
2017-10-0417:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-17-303517
2017-07-2816:31 ET10-QQuarterly reportPeriod 2017-06-300001193125-17-240559
2017-07-2806:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-239274
2017-05-1216:17 ET8-K5.07 Shareholder vote results0001193125-17-168626
2017-05-0416:30 ET10-QQuarterly reportPeriod 2017-03-310001193125-17-158793
2017-05-0406:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-157221
2017-04-2006:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-129652
2017-03-1716:18 ETDEF 14AProxy statementPeriod 2017-05-110001193125-17-087381
2017-02-1016:11 ET10-KAnnual reportPeriod 2016-12-310001193125-17-038250
2017-02-0706:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-032470
2016-11-0706:50 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-16-760828
2016-10-2716:30 ET10-QQuarterly reportPeriod 2016-09-300001193125-16-749764
2016-10-2706:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-748651
2016-08-0916:21 ET8-K5.02 Departure or appointment of officers or directors0001193125-16-676791
2016-07-2816:25 ET10-QQuarterly reportPeriod 2016-06-300001193125-16-662264
2016-07-2806:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-661022
2016-05-1316:31 ET8-K5.07 Shareholder vote results0001193125-16-590452
2016-04-2816:29 ET10-QQuarterly reportPeriod 2016-03-310001193125-16-563830
2016-04-2806:53 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-560952
2016-03-1816:31 ETDEF 14AProxy statementPeriod 2016-05-120001193125-16-510400
2016-02-1116:34 ET10-KAnnual reportPeriod 2015-12-310001193125-16-459842
2016-02-0406:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-449916
2015-12-0816:31 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-15-397783
2015-11-0516:26 ET8-K5.07 Shareholder vote results0001193125-15-368359
2015-10-2916:37 ET10-QQuarterly reportPeriod 2015-09-300001193125-15-358077
2015-10-2906:46 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-15-356982
2015-09-1816:06 ETDEF 14AProxy statementPeriod 2015-11-030001193125-15-323425
2015-07-3016:39 ET10-QQuarterly reportPeriod 2015-06-300001193125-15-270938
2015-07-3008:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-15-269398
2015-06-0916:14 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-15-217985
2015-05-1808:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-15-190959
2015-05-0817:06 ET8-K5.07 Shareholder vote results0001193125-15-179810
2015-04-3016:20 ET10-QQuarterly reportPeriod 2015-03-310001193125-15-161981
2015-04-3008:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-15-159084
2015-03-2016:03 ETDEF 14AProxy statementPeriod 2015-05-070001193125-15-100152
2015-03-1716:07 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-15-095350
2015-03-1316:06 ET8-K5.02 Departure or appointment of officers or directors0001193125-15-091178
2015-02-0916:26 ET10-KAnnual reportPeriod 2014-12-310001193125-15-039201
2015-01-2908:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-15-024547
2014-12-1816:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-14-446885
2014-10-3016:22 ET10-QQuarterly reportPeriod 2014-09-300001193125-14-389697
2014-10-3008:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-14-388382
2014-07-3116:27 ET10-QQuarterly reportPeriod 2014-06-300001193125-14-289739
2014-07-3108:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-14-288344
2014-05-0816:47 ET8-K5.07 Shareholder vote results0001193125-14-190177
2014-05-0116:24 ET10-QQuarterly reportPeriod 2014-03-310001193125-14-177190
2014-05-0108:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-14-174733
2014-03-2117:16 ETDEF 14AProxy statementPeriod 2014-05-080001193125-14-110584
2014-02-1917:09 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-14-058946
2014-02-1218:08 ET10-KAnnual reportPeriod 2013-12-310001193125-14-045903

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:14 ET. Listed shows no prices and gives no investment advice.